ORAMED PHARMACEUTICALS INC. (ORMP) Operating margin 2016–2025
ORAMED PHARMACEUTICALS INC. (ORMP) operating margin by fiscal year — reported operating income divided by reported revenue.
-754.4%FY2025 · since FY2016: -1561.6% → -754.4%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -754.4% | — |
| FY2023 | -1176.8% | +325.2 pp |
| FY2022 | -1502.0% | -605.8 pp |
| FY2021 | -896.2% | -462.3 pp |
| FY2020 | -433.8% | +107.4 pp |
| FY2019 | -541.3% | +11.1 pp |
| FY2018 | -552.3% | -113.8 pp |
| FY2017 | -438.6% | +1123.1 pp |
| FY2016 | -1561.6% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice